Connolly RM, Leal JP, Solnes L, Huang CY, et al. Updated Results of TBCRC026: Phase II Trial Correlating Standardized Uptake Value
With Pathological Complete Response to Pertuzumab and Trastuzumab in Breast
Cancer. J Clin Oncol 2021 May 17:JCO2100280. doi: 10.1200/JCO.21.00280.
PMID: 33999652